Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Executive Vice President, Chief of Product Development and Medical Officer
-
Stock Symbol
-
BTAI on Nasdaq
Vincent O'Neill - trading volume in the past year for BioXcel Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
19.6K |
$10.8K |
$0.55 |
Oct 3, 2024 |
Direct |
|
|
Restricted Stock Units |
3.13K |
$2.16K |
$0.69 |
Sep 14, 2024 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
0 |
|
|
Mar 14, 2023 |
Direct |
Common Stock |
0 |
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.